Track topics on Twitter Track topics that are important to you
Austin, Texas, March 6, 2017 /3BL Media/ On March 10, the LIVESTRONG Foundation will host an unveiling reception for The Hero’s Journey Art, an art installation created by sculptor John Magnan in collaboration with Eli Lilly and Company to honor clinical trial participants and raise awareness of the importance of clinical trial participation.
Lilly commissioned Magnan to build a series of crowd-sourced sculptures made from bricks decorated by thousands of the company’s clinical trial participants and community members. As an extension of its unique partnership with Lilly, LIVESTRONG will house one of The Hero’s Journey Art installations at its headquarters in Austin.
“LIVESTRONG is honored to be a part of The Hero’s Journey Art Project and to pay tribute to the thousands of clinical trial participants – and their loved ones – whose noble contributions to medical research make way for innovative treatments and procedures for millions of people fighting for their lives around the world,” said Greg Lee, President of LIVESTRONG. “This installation celebrates the determination of the human spirit to overcome painful struggles with strength and perseverance – and with the love, support and encouragement of their friends, families and communities.”
“Lilly is excited to see the broad research community, particularly patients, honored for their efforts in bringing new medicines to the world,” said Joe Kim, Senior Advisor in Clinical Innovation at Lilly. “Using art to publicly commemorate the clinical trial community is both rare and unexpected. We hope that this art will inspire others to engage with research to improve the well-being of future generations.”
The March 10 reception is open to the public and will take place at the LIVESTRONG headquarters in Austin (2201 E. Sixth Street) from 5:30 to 8:30 p.m. For more information about this event, contact Sarah Lilly. To learn more about The Hero’s Journey, visit HerosJourneyArt.com.
About the LIVESTRONG Foundation
The LIVESTRONG Foundation fights to improve the lives of people affected by cancer now. For 20 years, LIVESTRONG has been a voice for cancer survivors and has directly served more than 3.5 million people. A pioneer in the field of survivorship, LIVESTRONG remains a world leader in providing direct services to cancer patients and survivors, advocating for policies that enhance survivors’ quality of life and developing partnerships that create access to cancer programs across the country. Since 2007, the LIVESTRONG at the YMCA program has made a return to fitness and well-being possible for more than 40,000 survivors in more than 500 YMCA locations. Working with The University of Texas’ Dell Medical School, LIVESTRONG is building the LIVESTRONG Cancer Institutes to reinvent and redesign cancer care for and with people affected by cancer. If anyone you know needs cancer support, please visit LIVESTRONG.org/WeCanHelp. For more information about our programs and services, please visit LIVESTRONG.org.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.
KEYWORDS: Health, Business & Trade, LIVESTRONG, Eli Lilly, The Hero’s Journey, clinical trials
Original Article: LIVESTRONG and Eli Lilly and Company Honor Clinical Trials ParticipantsNEXT ARTICLE
Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in over 50 countries with just under 40,000 employees. Appr...
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...